Targeted Metabolomic Pathway Analysis and Validation Revealed Glutamatergic Disorder in the Prefrontal Cortex among the Chronic Social Defeat Stress Mice Model of Depression

J Proteome Res. 2016 Oct 7;15(10):3784-3792. doi: 10.1021/acs.jproteome.6b00577. Epub 2016 Sep 21.

Abstract

Major depressive disorder (MDD) is a severe psychiatric disease that has critically affected life quality for millions of people. Chronic stress is gradually recognized as a primary pathogenesis risk factor of MDD. Despite the remarkable progress in mechanism research, the pathogenesis mechanism of MDD is still not well understood. Therefore, we conducted a liquid chromatography-tandem mass spectrometry (LC-MS/MS) detection of 25 major metabolites of tryptophanic, GABAergic, and catecholaminergic pathways in the prefontal cortex (PFC) of mice in chronic social defeat stress (CSDS). The depressed mice exhibit significant reduction of glutamate in the GABAergic pathway and an increase of L-DOPA and vanillylmandelic acid in catecholaminergic pathways. The data of real-time-quantitative polymerase chain reaction (RT-qPCR) and Western blotting analysis revealed an altered level of glutamatergic circuitry. The metabolomic and molecular data reveal that the glutamatergic disorder in mice shed lights to reveal a mechanism on depression-like and stress resilient phenotype.

Keywords: CSDS; LC-MS/MS; depression; glutamate; metabolomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Depression / metabolism*
  • Depression / physiopathology
  • Disease Models, Animal
  • Glutamic Acid / metabolism*
  • Metabolic Networks and Pathways*
  • Metabolomics / methods*
  • Mice
  • Prefrontal Cortex / metabolism*
  • Real-Time Polymerase Chain Reaction
  • Stress, Psychological / metabolism

Substances

  • Glutamic Acid